Researchers are excited about the medication , a novel dual compound showing remarkable data in early trials for size loss . It functions by targeting both systems: GLP-1 and GIP, that , when https://aprilcbtu118426.ivasdesign.com/61936995/the-new-possibility-for-size-loss